# OnCo record cobolimab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cobolimab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cobolimab" ;
  schema:name "Cobolimab"@en ;
  schema:description "Cobolimab is an experimental investigational agent whose form is not stated in the registry from GlaxoSmithKline in phase 3 trials for non-small-cell lung cancer, melanoma and hodgkin lymphoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/cobolimab/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Cobolimab> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "antibody (INN stem -mab; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/osteosarcoma/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/rhabdomyosarcoma/> ;
  onco:technologies <https://onco.cc/technologies/tim3-blockade/> ;
  onco:companies <https://onco.cc/companies/gsk/> ;
  onco:trials <https://onco.cc/trials/nct04655976/>, <https://onco.cc/trials/nct06521567/> .